Hypofractionated radiotherapy vs temozolomide in glioblastoma RPA V-VI: A randomized phase II trial

Authors
Category Primary study
JournalRadiotherapy and Oncology
Year 2018
This article has no abstract
Epistemonikos ID: c7e3953f3f155c735bce894c26408fbde68d0cff
First added on: Feb 09, 2025